Hirtle Callaghan & CO LLC Danaher Corp Transaction History
Hirtle Callaghan & CO LLC
- $2.57 Billion
- Q1 2025
A detailed history of Hirtle Callaghan & CO LLC transactions in Danaher Corp stock. As of the latest transaction made, Hirtle Callaghan & CO LLC holds 5,259 shares of DHR stock, worth $970,495. This represents 0.04% of its overall portfolio holdings.
Number of Shares
5,259Holding current value
$970,495% of portfolio
0.04%Shares
4 transactions
Others Institutions Holding DHR
# of Institutions
2,501Shares Held
559MCall Options Held
6.75MPut Options Held
3.37M-
Vanguard Group Inc Valley Forge, PA60MShares$11.1 Billion0.23% of portfolio
-
Black Rock Inc. New York, NY50.5MShares$9.33 Billion0.29% of portfolio
-
State Street Corp Boston, MA27.5MShares$5.07 Billion0.24% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD19.6MShares$3.62 Billion0.49% of portfolio
-
Wellington Management Group LLP Boston, MA17.7MShares$3.27 Billion0.72% of portfolio
About DANAHER CORP
- Ticker DHR
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 727,963,008
- Market Cap $134B
- Description
- Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...